(Q40288670)

19 September 2017

Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels (English)

1 reference

19 September 2017

2

1 reference

19 September 2017

Daniela Alfano

1

1 reference

PubMed ID

16632475

19 September 2017

M Patrizia Stoppelli

series ordinal

3

1 reference

PubMed ID

16632475

19 September 2017

language of work or name

English

0 references

publication date

21 April 2006

1 reference

Journal of Biological Chemistry

19 September 2017

1 reference

19 September 2017

281

1 reference

19 September 2017

17758-17767

1 reference

19 September 2017

26

1 reference

19 September 2017

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

c-MYC: more than just a matter of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Cooperative interaction between c-myc and bcl-2 proto-oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Analysis of the transcriptional program induced by Raf in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

uPAR: a versatile signalling orchestrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Urokinase receptor: a molecular organizer in cellular communication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Autocrine saturation of pro-urokinase receptors on human A431 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Disruption of epithelial cell-matrix interactions induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Human RPE cell lysis of extracellular matrix: functional urokinase plasminogen activator receptor (uPAR), collagenase and elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

The cleavage of the urokinase receptor regulates its multiple functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Cellular survival: a play in three Akts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Pericellular plasmin induces smooth muscle cell anoikis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Anti-apoptotic action of macrophage stimulating protein (MSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Urokinase receptor and integrin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Increased Bcl-xL expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M601812200

21 January 2018

Identifiers

DOI

10.1074/JBC.M601812200

1 reference

19 September 2017

1 reference

PubMed ID

16632475